Assistant Professor, Medicine, Medical College of Wisconsin
Hematology
Dr. Marcelo C. Pasquini, MD
|
|
Give Review
Marcelo Pasquini is an expert in the field of Hematology. He studied medicine at Medical College of Wisconsin Affiliated Hospitals. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Marcelo C. Pasquini, MD is a published doctor and has 67 publications published. The lastest was: 'Localization of the murine homolog of the anaplastic lymphoma kinase (AlK) gene on mouse chromosome 17.' Marcelo Pasquini accepts Medicare payments and is registered with Medicare.gov.
Publications
- Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.
- Monocyte recovery at day 100 is associated with improved survival in multiple Myeloma patients who undergo allogeneic hematopoietic cell transplantation.
- A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality.
- Guidelines for Defining and Implementing Standard Episode of Care for Hematopoietic Stem Cell Transplantation within the Context of Clinical Trials.
- Identification and Utilization of Donor and Recipient Genetic Variants to Predict Survival After HCT: Are We Ready for Primetime?
- Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation.
- Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplan...
- Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis.
- Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosis.
- Comparison of non-myeloablative conditioning regimens for lymphoproliferative Disorders.
- Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2014.
- Is 'informed consent' an 'understood consent' in hematopoietic cell transplantation?
- Phase III clinical trial steroids/mycophenolate mofetil vs steroids/placebo as therapy for Acute graft-versus-host disease: BMT CTN 0802.
- Tacrolimus/sirolimus versus tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic hematopoietic cell transplantation.
- Acute GVHD: a bench to bedside update.
- Lenalidomide Maintenance for High-Risk Multiple Myeloma after Allogeneic Hematopoietic Cell Transplantation.
- Allogeneic hematopoietic cell transplant for Acute myeloid leukemia: Current state in 2013 and future directions.
- Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts.
- Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation.
- Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
- Divergent Effects of Novel Immunomodulatory Agents and Cyclophosphamide on the Risk of Engraftment Syndrome after Autologous Peripheral Blood Stem Cell Transplantation...
- Anatomy of a Successful Practice-Changing Study: A Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group Collaboration.
- Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in...
- Transplants for Autoimmune Diseases in North and South America: A Report of the Center for International Blood and Marrow Transplant Research (CIBMTR).
- Hematopoietic cell transplantation in Latin America.
- Hematopoietic cell transplantation for chronic myeloid Leukemia in developing countries: perspectives from Latin America in the post-tyrosine kinase inhibitor era.
- Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for Acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials...
- Trends of Hematopoietic Stem Cell Transplantation in the Eastern Mediterranean Region, 1984-2007.
- Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?
- Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell-Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in ...
- Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for Acute myelogenous leukemia (AML) in adults.
- Second unrelated donor hematopoietic cell transplantation for primary Graft failure.
- Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies.
- Allogeneic transplantation for therapy-related myelodysplastic syndrome and Acute myeloid leukemia.
- 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and ...
- HLA-matched sibling hematopoietic stem cell transplantation for fanconi Anemia: comparison of irradiation and nonirradiation containing conditioning regimens.
- On the probability of using cord blood.
- Lifetime probabilities of hematopoietic stem cell transplantation in the U.S.
- Hematopoietic cell transplantation in Acute promyelocytic leukemia: a comprehensive review.
- New questions about transplantation in multiple Myeloma.
- Localization of the murine homolog of the anaplastic Lymphoma kinase (AlK) gene on mouse chromosome 17.
- Bradykinesia in patients with obsessive-compulsive disorder.
- Immunotherapy with interferon-alpha in patients affected by Chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depre...
- Influence of cognitive impairment on the institutionalisation rate 3 years after a stroke.
- Detection and treatment of depressive and anxiety disorders among Cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.
- Delayed poststroke dementia: a 4-year follow-up study.
- Central Venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures.
- The human Penumbra gene is mapped to a region on chromosome 7 frequently deleted in Myeloid malignancies.
- Low-dose subcutaneous alemtuzumab in refractory Chronic lymphocytic leukaemia (CLL): results of a prospective, single-arm multicentre study.
- Endothelial precursors and mature endothelial cells are increased in the peripheral blood of myelodysplastic Syndromes.
- Cure of multiple Myeloma -- more hype, less reality.
- Access to hematopoietic stem cell transplantation: effect of race and sex.
- Tocilizumab for the treatment of steroid refractory Graft-versus-host disease.
- Defining the intensity of conditioning regimens: working definitions.
- Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant ...
- Bone marrow transplantation for diamond-blackfan Anemia.
- NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committ...
- Role of reduced intensity conditioning in allogeneic hematopoietic cell transplantation for patients with multiple Myeloma.
- Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for Acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Tr...
- HLA-identical sibling allogeneic transplants versus chemotherapy in Acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between th...
- Impact of Graft-versus-host disease on survival.
- Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple Myeloma: a systematic review and meta-analysis.
- Hematopoietic stem cell transplantation: a global perspective.
- Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic Anemia.
- Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple Myeloma (BMT CT...
- Haematopoietic cell transplants in Latin America.
Schools
Universidade Estadual De Londrina Centro De Ciencias Da Saude
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Breast Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Medical College of Wisconsin Affiliated Hospitals -
University of Utah -
Jackson Memorial Hospital - Jackson Health System
Hospital
-
Froedtert Memorial Lutheran Hospital
Drug Facts
| NPI NUMBER | 1174575856 | |
| NPPES Provider LastName | PASQUINI | |
| NPPES Provider FirstName | MARCELO | |
| NPPES Provider ZIPCode | 532263522 | |
| NPPES Provider State | WI | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 341.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 3.23 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1174575856 |
| Last Name Of The Provider | PASQUINI |
| First Name Of The Provider | MARCELO |
| View All |
Similar Doctors
|
|
Dr. Karen L. Dallas, MDCM
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicholas P. Webber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles H. Tiber, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nicholas Choong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph A. Libnoch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael W. Schuetz, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Christopher N. Bredeson, MD
This Doctor is OpenDoctor Recommended.
|